Bisphosphonates in the Treatment of Metastatic Breast Cancer
- 1 January 2001
- journal article
- review article
- Published by Springer Nature in Journal of Mammary Gland Biology and Neoplasia
- Vol. 6 (4) , 477-485
- https://doi.org/10.1023/a:1014795216669
Abstract
The skeleton is the most common site of metastatic disease in breast cancer and the most common site of first distant relapse. Bone metastases in breast cancer are the source of considerable...Keywords
This publication has 47 references indexed in Scilit:
- Breast Cancer Cells Release Factors That Induce Apoptosis in Human Bone Marrow Stromal CellsJournal of Bone and Mineral Research, 2001
- Bisphosphonates Induce Breast Cancer Cell Death In VitroJournal of Bone and Mineral Research, 2000
- Suppressed Bone Turnover by Bisphosphonates Increases Microdamage Accumulation and Reduces Some Biomechanical Properties in Dog RibJournal of Bone and Mineral Research, 2000
- Zoledronate Is a Potent Inhibitor of Myeloma Cell Growth and Secretion of IL-6 and MMP-1 by the Tumoral EnvironmentJournal of Bone and Mineral Research, 1999
- A Dose-Finding Study of Zoledronate in Hypercalcemic Cancer PatientsJournal of Bone and Mineral Research, 1999
- The Role of Geranylgeranylation in Bone Resorption and Its Suppression by Bisphosphonates in Fetal Bone Explants In Vitro: A Clue to the Mechanism of Action of Nitrogen-Containing BisphosphonatesJournal of Bone and Mineral Research, 1999
- Clodronate and Liposome-Encapsulated Clodronate Are Metabolized to a Toxic ATP Analog, Adenosine 5′-(β,γ-Dichloromethylene) Triphosphate, by Mammalian Cells In VitroJournal of Bone and Mineral Research, 1997
- Inhibition of osteolytic bone metastasis of breast cancer by combined treatment with the bisphosphonate ibandronate and tissue inhibitor of the matrix metalloproteinase-2.Journal of Clinical Investigation, 1997
- Secretory Products of Breast Cancer Cells Specifically Affect Human Osteoblastic Cells: Partial Characterization of Active FactorsJournal of Bone and Mineral Research, 1997
- Acid extrusion is induced by osteoclast attachment to bone. Inhibition by alendronate and calcitonin.Journal of Clinical Investigation, 1995